Literature DB >> 6933255

Reassessment of cancer predisposition of Fanconi anemia heterozygotes.

M Swift, R J Caldwell, C Chase.   

Abstract

The hypothesis that heterozygotes for the Fanconi anemia (FA) gene are predisposed to cancer was investigated by comparing the observed and expected numbers of cancer cases and deaths in 25 extended families of FA probands. This study demonstrated no overall excess of cancers of cancer deaths for any age or sex category of blood relatives and no unusual number of cancers among the obligate heterozygotes. Deaths from leukemia among blood relatives were fewer than expected. For bladder, stomach, and breast cancer there were more deaths and cases among blood relatives than expected, although the differences were not statistically significant. An excess of deaths at an early age from lung and stomach cancer was noted among the FA blood relatives. Among spouse controls there were fewer deaths than expected from bladder, stomach, and breast cancer; thus the expected numbers may be inappropriately high for this sample. Therefore, the question of predisposition to bladder, stomach, and breast cancer among FA heterozygotes remains unresolved.

Entities:  

Mesh:

Year:  1980        PMID: 6933255

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  13 in total

Review 1.  Fanconi anaemia.

Authors:  M D Tischkowitz; S V Hodgson
Journal:  J Med Genet       Date:  2003-01       Impact factor: 6.318

2.  How high are carrier frequencies of rare recessive syndromes? Contemporary estimates for Fanconi Anemia in the United States and Israel.

Authors:  Philip S Rosenberg; Hannah Tamary; Blanche P Alter
Journal:  Am J Med Genet A       Date:  2011-07-07       Impact factor: 2.802

3.  Heterozygous carriers for Bloom syndrome exhibit a spontaneously increased micronucleus formation in cultured fibroblasts.

Authors:  B Frorath; U Schmidt-Preuss; U Siemers; M Zöllner; H W Rüdiger
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

4.  Spontaneous 6-thioguanine-resistant lymphocytes in Fanconi anemia patients and their heterozygous parents.

Authors:  E Wunder; T M Schroeder
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

5.  Response of lymphocytes from Fanconi's anemia patients and their heterozygous relatives to 8-methoxy-psoralene in a cloning survival test system.

Authors:  E Wunder; B Fleischer-Reischmann
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

6.  Body proportions in Fanconi anemia heterozygotes.

Authors:  S Mohan; P Lakshminarayanan; P Sowmya; M Venkatadesikalu; V Pushpa
Journal:  Indian J Pediatr       Date:  2000-11       Impact factor: 1.967

7.  The incidence and gene frequency of ataxia-telangiectasia in the United States.

Authors:  M Swift; D Morrell; E Cromartie; A R Chamberlin; M H Skolnick; D T Bishop
Journal:  Am J Hum Genet       Date:  1986-11       Impact factor: 11.025

8.  Nuclear Pedigree Criteria for the Identification of Individuals Suspected to be at Risk of an Inherited Predisposition to Renal Cancer.

Authors:  Aleksandra Tołoczko-Grabarek; Andrzej Sikorski; Marek Brzosko; Jan Lubiński
Journal:  Hered Cancer Clin Pract       Date:  2005-08-15       Impact factor: 2.857

9.  Congenital malformations and developmental disabilities in ataxia-telangiectasia, Fanconi anemia, and xeroderma pigmentosum families.

Authors:  K Welshimer; M Swift
Journal:  Am J Hum Genet       Date:  1982-09       Impact factor: 11.025

10.  BACH1 Ser919Pro variant and breast cancer risk.

Authors:  Pia Vahteristo; Kristiina Yliannala; Anitta Tamminen; Hannaleena Eerola; Carl Blomqvist; Heli Nevanlinna
Journal:  BMC Cancer       Date:  2006-01-24       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.